Navigation Links
New binding target for oncogenic viral protein

The DNA tumor virus simian virus 40 produces the Large T antigen which inactivates two of the cell's most important cancer-preventing proteins, p53 and pRb. In a study published in the Journal of Biological Chemistry, researchers at the Fred Hutchinson Cancer Research Center report the discovery of an additional target for T antigen--a protein called Fbw7.

The Fbw7 gene is located in a chromosomal region that is deleted in up to 30% of human tumors. "Fbw7 is itself an important tumor suppressor which makes it an attractive choice for inactivation by Large T," explained Dr. Markus Welcker, the study's first author.

The research appears as the "Paper of the Week" in the March 4 issue of the Journal of Biological Chemistry, an American Society for Biochemistry and Molecular Biology journal.

DNA tumor viruses proliferate by hijacking their host cell's DNA replication machinery. In order to do this, they have evolved mechanisms to override normal cellular replication controls. Simian virus 40 (SV40) accomplishes this task by producing the highly oncogenic large T antigen. This protein corrupts the cellular checkpoint mechanisms that guard cell division and the transcription, replication and repair of DNA. T antigen also inactivates some of the most important proteins that protect cells against malignant transformation, including tumor suppressor proteins p53 and pRb.

In the Journal of Biological Chemistry paper, Dr. Welcker and Dr. Bruce Clurman report that T antigen also binds to another tumor suppressor, Fbw7. This protein is part of a ubiquitin ligase complex that adds ubiquitin to proteins to mark them for destruction by the cell. Fbw7 recognizes a destruction signal on certain proteins that need to be degraded and brings them in close proximity to the enzymes that attach ubiquitin. The proteins recognized by Fbw7 play key roles in cell division, cell growth, differentiation, and cell death.

"These proteins are also some of the most broadly acting cellular oncogenes, and include cyclin E, c-Myc, Notch, and c-Jun," noted Dr. Clurman. "When Fbw7 is mutated in cancers, deregulation of these oncogenic Fbw7 targets is thought to contribute to cancer. SV40 T antigen contains a motif that mimics the destruction signal found in these proteins." However, unlike the other substrates recognized by Fbw7, T antigen is not destroyed by the cell.

Drs. Clurman and Welcker suspect that by acting as a decoy and binding to Fbw7, T antigen protects cellular Fbw7 targets that facilitate viral replication and tumorigenesis.

"I think this work underlines the importance of Fbw7 as an emerging tumor suppressor and the consequences of its loss in tumors," Dr. Welcker emphasized.

"The study of DNA tumors viruses has been an extremely important tool in understanding the cellular pathways that regulate cell division and are disrupted in cancer. Understanding the mechanisms through which these viruses interact with the cellular machinery that regulates cell division may lead to new insights into the pathways that cause cancer. This is an important step to designing new cancer treatment strategies that target these pathways," concluded Dr. Clurman.


'"/>

Source:American Society for Biochemistry and Molecular Biology


Related biology news :

1. Ancient olfaction protein is shared by many bugs, offering new pest control target
2. A bacterial genome reveals new targets to combat infectious disease
3. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
4. Researchers identify target for cancer drugs
5. Study reveals candidate targets for anti-retroviral therapeutics
6. MUHC researchers make cancer target breakthrough
7. Future diabetes drugs may target new protein interaction
8. Smart drug targets deadly brain cancer
9. NHGRI targets 12 more organisms for genome sequencing
10. While on trail of dioxin, scientists pinpoint cancer target of green tea
11. Moffitt-USF head toward first human trials of anti-cancer drug that targets protein AKT
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... ... November 15, 2018 , ... Firmex today released new research ... surveyed over 480 investment bankers and M&A advisors worldwide to compile the third annual ... on the key findings in the report. , Highlights in the 2018-19 Report:, ...
(Date:11/15/2018)... YORK (PRWEB) , ... November 14, 2018 , ... ... Sinai have developed a tool that speeds up the analysis and publication of ... researchers communicate results of their studies. Until now, the primary method available to ...
(Date:11/15/2018)... ... November 14, 2018 , ... ... lab, will present new scientific evidence on gene-disease relationships and how it supports ... to be held in Atlanta, November 14-17. , Ambry has been selected ...
Breaking Biology News(10 mins):
(Date:10/18/2018)... HAYWARD, Calif. (PRWEB) , ... October 18, 2018 ... ... its CLIA-certified genomic sequencing laboratory in the San Francisco Bay Area has received ... in quality, operations, and patient safety. , Predicine received CAP accreditation for its ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... and his associate, Dr. Michael Kang, are offering current and new patients the ... results thanks to the emerging, proven treatment technology known as Piezosurgery® . ...
(Date:10/17/2018)... ... 2018 , ... PathSensors’ cutting-edge CANARY based assays for the ... and Plant Health Inspection Service for use in regulatory diagnostics. By going through ... they will be able to rapidly and accurately test and identify these damaging ...
(Date:10/16/2018)... ... October 16, 2018 , ... Infinity ... Congressional briefing on a revolutionary technology that effectively treats pain, reduces the need ... Healing, testified on how technology using photobiomodulation (PBM) has been effective for the ...
Breaking Biology Technology: